Last update:

Oncology & Cancer news

Oncology & Cancer

Failure in a CAR T cell trial could unlock multiple treatments for acute myeloid leukemia

In the clinical battle against leukemia, recent breakthroughs in chimeric antigen receptor T cells (CAR T) have given patients and doctors an unprecedented weapon. CAR T cell therapy has demonstrated efficacy in treating ...

Oncology & Cancer

Mouse model suggests bacterial-derived metabolites may promote prostate cancer

Every year, over 1.5 million new cases of prostate cancer are diagnosed throughout the world. As one of the leading causes of death for men in multiple countries, understanding the risk factors for prostate cancer has become ...

Oncology & Cancer

Study explores novel therapeutic treatment for glioblastoma

Glioblastoma (GBM) is the most lethal brain tumor, with a median survival rate of merely 12-16 months after diagnosis. Despite surgical, radiation and chemotherapy treatments, the two-year survival rate for GBM patients is ...

Oncology & Cancer

Study unveils the role of gamma-delta T cells in cancer immunology

A new study published in Cell Reports Medicine reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer ...

Oncology & Cancer

New single-cell study provides novel insights into gastric cancer

A new study led by researchers at The University of Texas MD Anderson Cancer Center provides a deeper understanding of the evolution of the tumor microenvironment during gastric cancer progression. Highlights of the study, ...

Oncology & Cancer

Study supports 'catch up' HPV test in older women

For women over the age of 65 who have never had a high-risk human papillomavirus (HPV) test, a "catch up" HPV screening intervention may improve cervical cancer prevention by detecting more cervical pre-cancer lesions as ...

Oncology & Cancer

A two-for-one approach to boost melanoma immunotherapy

New research from Sanford Burnham Prebys has helped explain how melanoma evades the immune system and may guide the discovery of future therapies for the disease. The study found that a protein known to be active in immune ...

Oncology & Cancer

Unlocking the mystery of long-lasting cancer treatment

New insights explaining why some children have a longer remission than others after having cutting-edge CAR T-cell therapy for leukemia have been revealed by researchers at UCL, Great Ormond Street Hospital, and the Wellcome ...

Oncology & Cancer

Scientists develop new technology for targeted cancer therapy

Acoustic tweezers can control target movement through the interaction of momentum between an acoustic wave and an object. Due to their high tissue penetrability and strong acoustic radiation force, such tweezers overcome ...